• STAT+: A cautionary tale: How one biotech stock trader lost a small fortune, but emerged wiser

    10 days ago - By STAT

    Too many of my Twitter interactions with biotech-loving retail investors are unpleasant. If I write an article raising doubts about a small drugmaker's clinical trial results, or if I call out misleading statements made by an overly promotional biotech CEO, the responses I receive from people who own the stock generally run the gamut from “f-k you, you clueless a-hole” to “I hope you get cancer and die.”
    And sometimes, the replies to my work get really nasty. Continue to STAT+ to read the full story...
    Read more ...